Using an expression gene trapping strategy, we have identi®ed and characterized two novel hematopoietic genes, Hzf and Hhl. Embryonic stem (ES) cells containing a gene trap vector insertion were cultured on OP9 stromal cells to induce hematopoietic differentiation and screened for lacZ reporter gene expression. Two ES clones displaying lacZ expression within hematopoietic cells in vitro were used to generate mice containing the gene trap integrations. Paralleling this in vitro expression pattern, both Hzf and Hhl were expressed in a tissuespeci®c manner during hematopoietic development in vivo. Hzf encodes a novel protein containing three C 2 H 2 -type zinc ®ngers predominantly expressed in megakaryocytes and CFU-GEMM. Hhl encodes a novel protein containing a putative phosphotyrosine binding (PTB) domain expressed in megakaryocytes, CFU-GEMM and BFU-E. These results demonstrate the utility of expression trapping to identify novel hematopoietic genes. Future studies of Hzf and Hhl should provide valuable information on the role these genes play during megakaryocytopoiesis. q
Introduction
Many of the molecular events involved in the embryonic development and differentiation of hematopoietic cells remain to be elucidated. In the mouse, several genetic approaches have been employed in an attempt to identify and determine the function of novel hematopoietic genes. One approach involves the cloning of mutant loci responsible for altered hematopoietic phenotypes in mice harboring naturally occurring or induced mutations (Bernstein et al., 1991; Bedell et al., 1997a,b) . A complementary approach involves the generation of new mutations in the mouse germline by homologous recombination in embryonic stem (ES) cells to mutate candidate hematopoietic genes (Gurney et al., 1994; Lieschke et al., 1994; Fischer et al., 1995; Shalaby et al., 1995; Shivdasani and Orkin, 1996; Bernstein et al., 1996; Cheng et al., 1996) . Both approaches are labor intensive, the former being restricted to the repertoire of mutant phenotypes while the latter is restricted to previously identi®ed genes. Thus, neither approach is easily applied on a genome-wide level. In contrast, gene trapping in ES cells provides an effective approach to screen and analyze novel genes because it simultaneously provides information on the pattern of expression in vivo, sequence and resulting mouse mutant phenotype (Gossler et al., 1989; Friedrich and Soriano, 1991; Skarnes et al., 1992; von Melchner et al., 1992; Wurst et al., 1995; Evans et al., 1997; Sam et al., 1998; Stanford et al., 1998) .
One potential drawback of gene trapping is the very large size of the mammalian genome and hence the integration of the gene trap vector into genes that may not be of immediate interest. To pre-select for genes that are preferentially expressed in hematopoietic cells, we have developed an expression trapping strategy that takes advantage of the developmental potential of ES cells to differentiate into diverse cell lineages in vitro, including hematopoietic cells (Doetschman et al., 1985; Wiles and Keller, 1991;  Wang et al., 1992; Keller et al., 1993; Maltsev et al., 1993; Rohwedel et al., 1994; Bain et al., 1995) . Upon the removal of leukemia inhibitory factor (LIF), ES cells spontaneously differentiate into embryoid bodies (EBs), structures which resemble postimplantation embryos, comprising a number of cell lineages and structures, including blood islands which contain hematopoietic precursor cells. Secondary plating of cells obtained from dissociated EBs in semisolid cultures, containing various cytokines and growth factors, results in the growth of colonies of erythroid, myeloid and lymphoid lineages (Doetschman et al., 1985; Wiles and Keller, 1991; Schmitt et al., 1991; Keller et al., 1993; Palacios et al., 1996; Kennedy et al., 1997) . Recently, we and others, have combined the in vitro differentiation of ES cells with gene trapping strategies to pre-screen for novel genes which respond to exogenous factors (Forrester et al., 1996; Sam et al., 1998) or are regulated in a tissue-speci®c manner prior to transmission into the mouse germline (Shirai et al., 1996; Baker et al., 1997; Stanford et al., 1998; Muth et al., 1998) . In order to screen large numbers of cell clones based on the expression of trapped genes in hematopoietic and endothelial cells, we combined an expression trap screen with an attached EB culture system to identify genes expressed within blood islands and endothelial cells (Stanford et al., 1998) . Muth et al. (1998) have developed a related approach to identify genes that are repressed during hematopoietic differentiation.
In this study, we have combined the ES cell-OP9 coculture system with gene trapping to screen for genes involved in the development and differentiation of hematopoietic cells. The OP9 stromal cell line induces ES cell differentiation into mesodermal colonies that, when replated, differentiate into single lineage precursors, without the addition of exogenous growth factors (Nakano et al., 1994) . Using this system, we have identi®ed two novel genes which we have called Hzf (hematopoietic zinc finger) and Hhl (denoting the embryonic expression seen within hematopoietic cells, heart and liver) which are expressed in a regulated pattern during hematopoietic differentiation in vitro. These genes exhibit hematopoietic expression in vivo, indicating that this in vitro pre-screening strategy successfully predicts the expression of trapped genes in vivo. Within the hematopoietic compartment, both genes were expressed in megakaryocytes. Further characterization of these genes may provide insight into the cues required speci®cally during megakaryocyte differentiation.
Results

Isolation of hematopoietic gene trap clones
The PT1 gene trap vector, which contains a splice acceptor site immediately upstream of a promoterless lacZ reporter gene and the neo gene driven by the PGK-1 promoter, was introduced into ES cells (clone R1) by electroporation.
After selection of neo R colonies, clones were replica plated for freezing, analysis of lacZ expression by undifferentiated ES cells, and differentiation on OP9 stromal cells. Of 1350 neo R ES clones, 95% did not express lacZ (white clones) and 5% were lacZ positive (blue clones) in the undifferentiated state. Both white and blue clones were allowed to differentiate on OP9 cells and lacZ expression was monitored throughout hematopoietic differentiation. Two of the originally white clones (0.2% of the total number of clones) now expressed lacZ upon hematopoietic differentiation (Table 1) . One of these clones, 7H7, expressed lacZ at day 5 in mesoderm colonies which was subsequently downregulated during differentiation and not detected in hematopoietic cells by day 10 of culture. The other clone, Hhl, expressed lacZ at both the mesodermal and hematopoietic stages of differentiation (Fig. 1) . Approximately one-third of the hematopoietic clusters derived from Hhl ES cells expressed lacZ 12 days after intitiation of co-culture.
Of the 70 clones that expressed lacZ in the undifferentiated state (Table 1) , 97% (68/70) downregulated lacZ expression upon differentiation while two of the originally blue clones, Hzf and 4A11, expressed lacZ throughout the differentiation into hematopoietic cells (Table 1) . Clone Hzf expressed lacZ in only a few cells at the undifferentiated (day 2) and mesodermal stages (day 5). Interestingly, lacZ expression in Hzf was restricted to large cells located at the periphery of day 12 hematopoietic clusters ( Fig. 1) . Clone 4A11 was subsequently shown to be ubiquitously expressed in vivo and was not characterized further. In the remainder of this paper, we will describe the two hematopoietic regulated gene trap clones Hzf and Hhl.
In vivo expression analysis
We have previously shown that the in vitro patterns of lacZ expression in trapped ES clones accurately predicts the expression patterns observed in vivo (Stanford et al., 1998) . To determine whether the in vitro expression patterns of the trapped genes in the ES clones Hhl and Hzf were also recapitulated in vivo, we generated chimeric mice between these ES clones and diploid embryos and the trapped alleles were transmitted through the germ line to produce F 1 heterozygotes. In Hhl heterozygotes (Hhl/1), lacZ was expressed in the yolk sac and heart primordium at 8.5 days post coitum (d.p.c.) and in the heart, dorsal root ganglia and fetal liver after 12.5 d.p.c. (Fig. 2A,B) . Virtually all cells in 14.5 d.p.c. fetal liver were positive for X-gal staining (Fig. 2C) , and lacZ expression in the heart was localized to the endocardium and myocardium (Fig. 2D ). In Hzf heterozygotes (Hzf/1), lacZ was expressed in the somites, basal ganglia, apical ectodermal region of the limb buds and liver primordium in 9.5 d.p.c.. embryos (Fig. 2E) . Expression was also observed in the skin (Fig. 2H ), trigeminal ganglia, thymus, salivary gland and spinal cord, with punctate staining in the fetal liver around 14.5 d.p.c. (Fig. 2F ). The punctate staining in the liver was due to the restricted staining of large polynuclear cells resembling megakaryocytes (Fig. 2G) .
To characterize further the expression pattern of the trapped genes within the hematopoietic compartment, bone marrow cells were isolated from adult mice and analyzed for lacZ expression. Unfractionated cells obtained from Hzf/1 mice expressed high levels of lacZ in about 2% of total bone marrow cells while up to 80% (ranging from very high to low levels of expression) of cells obtained from Hhl/1 mice were lacZ-positive (for example, see 1 Hzf/1 cells co-expressed lacZ; whereas only 14% of the CD61 1 fraction obtained from Hhl/1 cells also expressed lacZ (data not shown).
This pattern of lacZ expression was further supported by the expression of lacZ within most megakaryocyte colony forming units (CFU-Mk) generated from Hhl/1 and Hzf/1 bone marrow in a serum-free agarose assay in the presence of TPO, IL-3 and SLF (Fig. 4) . In addition to expression in megakaryocytes, lacZ was expressed in cells within CFU-GEMM and at a low frequency in cells within CFU-M colonies, with no expression observed in CFU-GM, G or BFU-E colonies derived from Hzf/1 bone marrow cells (Fig. 4) . In contrast, lacZ was expressed to high levels in BFU-E and cells within CFU-GEMM colonies from Hhl/1 bone marrow cells. Expression was also observed at a low frequency in cells within CFU-M and the macrophage component of CFU-GM (Fig. 4) ; however, granulocytes did not express lacZ. Thus, the in vitro hematopoietic expression of both Hhl and Hzf was recapitulated in vivo.
Sequence analysis of Hzf and Hhl
To determine the primary sequence of the Hzf and Hhl trapped genes, lacZ fusion transcripts were cloned by 5 H rapid ampli®cation of cDNA ends (RACE). Primers corresponding to the sequence obtained by 5 H RACE were used for subsequent 3 H -RACE to obtain further sequence downstream of the vector integration site (Fig. 5) . The full length coding sequence for Hzf was obtained by 3 H -RACE (Fig.  5B) . A combination of RACE, inverse PCR and cDNA library screening was used to obtain partial sequences of Hhl with a full length coding sequence being obtained using 3 H -RACE (Fig. 5A ).
Hhl
The Hhl sequence is 1258 base pairs (bp) in length and contains an uninterrupted open reading frame (ORF) which encodes a putative protein of 298 amino acids (Fig. 5A) . The sequence of the ORF does not share signi®cant similarity with any known genes; however, the 3 H end of Hhl shares 88% DNA similarity over 126 bases to a murine expressed sequence tag (EST) isolated from a heart cDNA library (accession # AA919544) using the NCBI search program. The cloned Hhl cDNA may not contain the full-length message because it contains no classical AATAAA polyadenylation signal apparent in its 3 H UTR. Analysis of the translated sequence using Pro®leScan from the ExPasy Program also identi®ed a putative phosphotyrosine binding (PTB) domain between amino acids 78±192 (Fig. 5A) . Analysis of the translated sequence demonstrated 33% identity to a peptide encoded by a series of C. elegans cDNAs (accession # U41540) and 53% identity to the N-terminus of the recently identi®ed GTPase activating protein, GAPCenA (Cuif et al., 1999) , which also contains a PTB domain, using the NCBI Blast search program. 
Hzf
The Hzf sequence is 2300 bp in length and contains a 396 amino acid ORF with a putative translation start site at nucleotide 58 embedded in a consensus Kozak sequence. There is a single AATAAA polyadenylation signal in the 3
H UTR. Sequence analysis demonstrated that Hzf is a novel gene encoding a protein that includes three zinc ®nger motifs of the C 2 H 2 type (Fig. 5B) . The Hzf putative peptide has sequence similarity (22±32%) with several C 2 H 2 type zinc ®nger containing proteins, including the Xenopus laevis dsRBP-Zfa (Finerty and Bass, 1997) , the murine p53-inducible zinc ®nger protein, Wig-1 (Varmeh-Ziaie et al., 1997) and its rat homolog PAG608 protein (Israeli et al., 1997) .
RNA in situ hybridization and northern analysis
To determine whether the expression pattern of lacZ described above re¯ected the endogenous expression pattern of the trapped genes, we compared the X-gal staining pattern in 14.5 d.p.c. heterozygous embryos with the pattern of expression observed by RNA in situ hybridization analysis in wild type 14.5 d.p.c. embryos. As shown in Fig.  6 , Hhl transcripts were observed in the heart and liver while Hzf expression was restricted to large polynucleated cells within the liver. Northern blot analysis revealed Hhl transcripts of 3 different sizes in various tissues, suggesting that Hhl undergoes differential splicing in a tissue-speci®c manner in adult tissues (Fig. 7A) . A single 2.3 kb Hzf message was observed in the bone marrow and brains of adult mice and at lower levels in the thymus (Fig. 7B) .
Mice homozygous for the Hzf and Hhl gene trap insertion are viable and fertile
Hzf and Hhl heterozygous mice do not exhibit any apparent abnormalities and are fertile. Intercrosses of F 1 heterozygous mice for each of the Hhl and Hzf lines generated viable homozygous offspring at the appropriate Mendelian ratios. Mice homozygous for either insertion developed normally and did not exhibit any overt phenotype, including the numbers or types of hematopoietic progenitor cells, as determined by in vitro colony assays (data not shown). The absence of a discernible phenotype in these mice might re¯ect the absence of any effect on gene expression as the result of the integration of the PT1 vector into the Hhl and Hzf genes. To test this possibility, we analyzed expression of both Hzf and Hhl RNA transcripts in the brains of wild type and homozygous mice by RT-PCR using primers that span the integration site. For both Hzf and Hhl, we were able to amplify cDNA from both Hzf and Hhl homozygotes, suggesting that transcripts that extend 3 H to the integration site were present (Fig. 8 ). This conclusion was further con®rmed by Northern blot analysis using probes 3 H to the site of vector integration. This analysis demonstrated no differences in the levels or size of the transcripts obtained from wild-type or homozygous mice (data not shown). As shown in Fig. 5A , vector integration within the Hhl locus was within the 5 H UTR upstream of the ®rst coding exon. For Hzf, vector integration occurred downstream of the translational start site but upstream of an additional start site which also has a good Kozak consensus; therefore, alternative initiation codon usage may have occurred (Fig. 5B) . Thus, the sites of vector integration could account for the lack of mutagenesis of these trapped loci. Alternatively, splicing around the gene trap vector may have occurred which would also result in the expression of endogenous transcript. The latter has been reported to occur for a number of trapped genes Sera®ni et al., 1996; Yeo et al., 1997; Faisst and Gruss, 1998; Voss et al., 1998; McClive et al., 1998) and splicing around targeting constructs has also been shown to occur, resulting in the generation of partially functional proteins rather than the expected null mutation (Melet et al., 1996) . Although, the vector insertions were not mutagenic in this study we have shown that insertion of the PT1 vector in several other loci results in embryonic lethality of homozygotes containing the gene trap vector (Stanford et al., 1998; Sam and Bernstein, unpublished data) .
Discussion
The objective of this study was to identify and characterize novel genes regulated during hematopoietic development. ES cell clones containing a random gene trap insertion were induced to differentiate into hematopoietic cells by co-culture on OP9 stromal cells. Clones were screened for lacZ expression in undifferentiated cells as well as at various stages during hematopoietic differentiation. From a total of 1350 ES clones, three clones exhibited lacZ expression within hematopoietic cells and two of these clones displayed a regulated expression pattern in vitro which was recapitulated during hematopoietic development in vivo. Molecular cloning and cDNA sequence analysis of the trapped genes in these two ES clones revealed that both genes, which we have denoted as Hzf and Hhl, are novel. Thus, this in vitro expression-based gene trap strategy is a successful approach for screening for novel hematopoietic genes.
In undifferentiated Hzf ES cells, lacZ expression was observed in only a few cells and this low frequency of expression was maintained throughout hematopoietic differentiation in vitro. The expression of Hhl was upregulated being ®rst detected in mesodermal colonies and later expressed in the majority of hematopoietic cells by day 12. During embryogenesis, expression of both trapped genes in hematopoietic cells was ®rst observed in the fetal liver and subsequently adult bone marrow. The low frequency of Hzf expression observed in vitro was recapitulated in vivo in the embryonic liver and in only 2% of adult bone marrow cells. The higher frequency of Hhl expression within day 12 hematopoietic cells in vitro was also recapitulated in vivo where up to 80% of adult bone marrow cells expressed lacZ. The majority of cells expressing Hzf were megakaryocytes, as determined by morphology, lacZ expression within CFU-Mk, and cell surface expression of the megakaryocyte-speci®c surface marker, CD61. Hzf was also expressed in other hematopoietic cell lineages contained within CFU-GEMM and at a very low frequency in CFU-M. Hhl was more widely expressed than Hzf within hematopoietic lineages, particularly in erythroid and mega- Fig. 4 . LacZ expression within bone marrow cell derived colonies. Bone marrow cells from Hzf and Hhl adult heterozygous mice were cultured in semi-solid agarose in the presence of TPO, IL-3 and SLF for the analysis of CFU-Mk. For the analysis of BFU-E, CFU-G, M, GM and GEMM bone marrow cells were plated in methylcellulose containing IL-3, IL-6, Epo and SLF. Colonies were either X-gal stained directly in the cultures or picked and then stained. High levels of X-gal staining were seen in CFU-Mk and CFU-GEMM for both Hzf and Hhl derived colonies. X-gal staining was seen in Hhl derived BFU-E but not in those derived from Hzf bone marrow cells. A low frequency of X-gal staining was detected in the macrophage component (depicted by the arrows) of CFU-M and GM for Hhl and only in CFU-M for Hzf. Photographs of cells from representative colonies are shown.
karyocyte cells as well as in the majority of cells comprising CFU-GEMM.
Both Hzf and Hhl were expressed in megakaryocytes, suggesting that these novel genes may play a role in the differentiation and/or maturation of this cell lineage. The major determinants of commitment to the megakaryocyte lineage and the regulation of gene expression in this lineage remain unclear. The generation of several knock-out mice have aided in our understanding of megakaryocyte differentiation. These include mice lacking thrombopoietin (TPO) or its receptor c-Mpl (Gurney et al., 1994; deSauvage et al., 1996; Alexander et al., 1996 ; Carver-Moore et al., 1996), NF-E2 (Shivdasani et al., 1995) , megakaryocytespeci®c loss of GATA-1 (Shivdasani et al., 1997) and Friend of GATA-1 (FOG) (Tsang et al., , 1998 . Mice lacking GATA-1 or NF-E2 also display defects in erythropoiesis (Shivdasani et al., 1995; Fujiwara et al., 1996) , suggesting that these transcription factors are co-expressed within a bipotential stem cell capable of giving rise to both mega- Fig. 8 . RT-PCR Analysis of Hzf and Hhl expression in normal and trapped mice. RNA was isolated from brain and ampli®ed by RT-PCR from genotyped Hzf and Hhl mice. Ampli®ed products were then southern blotted and hybridized with gene speci®c or lacZ probes. Ampli®ed products were obtained from Hhl (A) and Hzf (B) homozygous mice using a primer 5 H and another 3 H to the vector integration site demonstrating that endogenous transcript 3
H to the integration site had not been disrupted. Wild-type mice were distinguished from mutant mice due to the lack of ampli®cation of a Hzf or Hhl-lacZ fusion product using a primer 5 H to the integration site and another complementary to the lacZ reporter gene. Fig. 6 . Hhl and Hzf RNA in situ hybridization analysis of 14.5 d.p.c. wild type embryos. Hhl in situ RNA expression was detected in the heart (Ht) and liver (Lv) (A) which corresponds to the lacZ expression seen within 14 d.p.c. Hhl/1 embryos (B). Hzf in situ RNA expression in the liver (C) was localized to large polynucleated cells (arrow heads (E and F)) which corresponds to the lacZ expression pattern in Hzf/1 embryos (D). Dark-®eld (E) and bright-®eld (F) photographs. Bar 500 mm (A,B,C,D), 50 mm (E,F). Fig. 7 . Northern blot analysis of total RNA from wild type mouse adult tissues using probes from the Hhl (A) and Hzf (B) genes. The GAPDH probe was used as an internal loading control (C).
karyocytes and erythroid cells. In our study, Hzf expression was observed in megakaryocytes but not in erythroid cells, suggesting that the function of this novel gene may be restricted to the megakaryocyte lineage. The presence of three zinc-®nger motifs in Hzf suggests that it may also be involved in transcriptional regulation in megakaryocytes. In contrast, Hhl was strongly expressed in both erythroid and megakaryocyte lineages. Given that both Hzf and Hhl were also expressed within multipotential CFU-GEMM colonies, these novel genes may be expressed in a bi/multipotential progenitor. The role these novel genes play in the megakaryocytic and erythroid lineages awaits the generation of mice with true null alleles for Hzf and Hhl.
In addition to expression in hematopoietic cells, Hhl was also expressed in the embryonic and adult heart and Hhl has signi®cant homology to an EST isolated from a heart cDNA library. Northern blot analysis of adult mouse tissue also demonstrated Hhl transcripts in the brain and kidney. In adult tissue, Hzf was also expressed in the brain. Thus, these genes may also be involved in other developmental processes outside of the hematopoietic system. The predicted Hhl peptide contains a putative PTB domain suggesting that Hhl may interact with tyrosine-phosphorylated proteins involved in signal transduction pathways (Kavanaugh and Williams, 1994; van der Geer and Pawson, 1995) .
One advantage of the OP9 gene trap screen described here is the speci®city in identifying genes expressed in hematopoietic cells. The ES/OP9 differentiation assay complements our previous gene trap screen utilizing an attached EB culture system (Stanford et al., 1998) . This latter approach gives rise to a number of identi®able cell types and structures, including blood islands which contain hematopoietic cells, angioblasts and mesodermal precursors to hematopoietic and/or endothelial cells. However, to determine whether lacZ-positive cells within blood islands are hematopoietic, they must subsequently be allowed to differentiate on OP9 cells. Using this two-stage approach, we have found that 70% of blood island positive clones express lacZ in hematopoietic cells (Stanford et al., 1998) . We have also observed important differences in the hematopoietic potential of mutant ES cells that are dependent on the in vitro culture conditions (Hidaka et al., 1999) .
The gene trap strategy presented in this study has resulted in the identi®cation of two novel genes with coincidence of expression within megakaryocytes. Insertion of the gene trap vector into Hzf and Hhl has allowed the molecular cloning of both genes and has also facilitated the rapid analysis of their expression during mouse embryogenesis. Neither insertion appears to have resulted in a null allele, a drawback of the current generation of gene trap vectors. We are currently designing new vectors to circumvent this problem and are generating null mutations in Hzf and Hhl by gene targeting via homologous recombination in ES cells to determine what role these genes play in hematopoiesis and other developmental pathways.
Experimental procedures
Cells
R1 embryonic stem cells from the 129/Sv strain (Nagy et al., 1993) were maintained on a layer of mitomycin C-treated embryonic ®broblasts in Dulbecco's modi®ed Eagle's culture medium, supplemented with leukemia inhibitory factor, 15% fetal calf serum, l-glutamine, and b -mercaptoethanol as previously described (Nagy, 1993) . The OP9 stromal cell line (a gift from Drs Takano and Honjo) was cultured in a -MEM containing 20% fetal calf serum (Nakano et al., 1994) .
Generation of trapped ES cell lines
The plasmid PT1-ATG (PT1 henceforth) contains the En-2 splice acceptor site positioned immediately upstream of the lacZ reporter gene with an ATG translational start site (Hill and Wurst, 1993) . The bacterial neomycin-resistance (neo) gene is driven by the phosphoglycerate kinase-1 (PGK-1) promoter. After electroporation of the ES cells with the PT1 vector and selection in G418, drug-resistant clones were plated into 96-well plates. Upon con¯uency, the cells were expanded into three 96-well plates. One plate was frozen; cells in the second plate were stained with X-galactosidase (X-gal); and cells in the third plate were used for hematopoietic differentiation on OP9 cells.
Analysis of b -galactosidase activity
b -galactosidase (b -gal) activity was analyzed by staining with 5-bromo 4-chloro 3-indolyl b -galactoside (X-gal; Boehringer Mannheim, Germany). Brie¯y, cells were washed once with phosphate buffered saline (PBS) and ®xed in 0.2% glutaraldehyde, 2 mM MgCl 2 and 5 mM EGTA in 100 mM Na 2 HPO 4 for 10 min at room temperature. Cell cultures were then washed three times for 5 min each in 100 mM Na 2 HPO 4 , 0.02% NP-40 and 2 mM MgCl 2 and stained overnight in X-gal staining solution (1 mg/ml X-gal, 5 mM K 3 Fe (CN) 6 , 5 mM K 4 Fe(CN) 6 , 2mM MgCl 2 , 0.02% NP-40 in 100 mM Na 2 HPO 4 ) directly in 96-or 6-well plates at 378C. Following X-gal staining, samples were washed overnight at 48C. Detection of b-gal activity in embryos was performed as described above except the ®xa-tive included 1.5% formaldehyde and ®xation was performed for between 30±60 min depending on the size of the embryo and washed 3 times each for 30 min.
Screening clones for hematopoietic expression
Differentiation of ES cells on OP9 stromal cells was performed essentially as previously described (Nakano et al., 1994) . The drug-resistant clones within each row of a 96-well plate which did not demonstrate X-gal staining in undifferentiated cultures (white clones) were pooled. The pooled clones were seeded onto con¯uent OP9 cell layers in 6-well plates at a density of 104.8. Immuno¯uorescence
Cells were stained with the¯uorescent b -gal substrate, uorescein di-b-d-galactopyranoside (FDG) as described by the manufacturer (Molecular Probes). Cells (10 6 ) were washed twice with phosphate buffered saline (PBS) and resuspended in 40 ml PBS containing 5% FCS. After 10 min of preincubation at 378C, cells were incubated with 40 ml prewarmed FDG (2 mM in water) for 75 s at 378C. FDG loading was terminated by adding 720 ml ice cold PBS containing 5% FCS. Cells were cytospun onto glass slides and examined under a¯uorescent microscope, prior to morphological examination by Wright±Giemsa staining. Cell surface expression of CD61 was performed by indirect immuno¯uorescence. Bone marrow cells were washed in PBS and incubated with anti-CD61 (PharMingen, ON, CA) for 30 min, washed twice, then incubated for 30 min with uorescein isothiocyanate (FITC) conjugated mouse antihamster IgG monoclonal antibody (PharMingen, ON, CA). Cells were washed twice and analysis was performed using a FACS cell sorter (Becton and Dickinson, Mountain View, CA).
CFU-C analysis
Bone marrow cells were cultured in methylcellulose containing the growth factors IL-3, IL-6, Epo and SCF (METHOCULT GF M3434; Stemcell Technologies). After 7±16 days, individual colonies were picked and stained with X-gal in a 96-well plate. Colony types were determined morphologically using Wright±Giemsa staining. For analysis of CFU-Mk, bone marrow cells were plated in 0.3% MegaCult serum-free base agarose (StemCell Technologies HCC-4701K) in the presence of recombinant murine IL-3 (20 ng/ml), TP0 (40 ng/ml) and SLF (50 ng/ml) (Hogge et al., 1997) and cultured for 18±21 days. The complete culture was stained with X-gal and CFU-Mk were examined microscopically.
